CW-270033

an injectable carbapenem with potent antimicrobial activity in vitro and in vivo; structure in first source

Also Known As:

(4R,5S,6S)-3-((2R,4S)-2-(N'-aminosulfonylamidinomethyl)pyrrolidin-4- yl)-thio-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxic acid; CW270033

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrrolidines: 115
    - CW-270033: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Carbapenems: 4837
        CW-270033: 1
Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Carbapenems: 4837
        CW-270033: 1

Experts

1.	Ha, Jong Ryul: 1 article (03/2007)
2.	Kim, Hong Gi: 1 article (03/2007)
3.	Kim, Jong Guk: 1 article (03/2007)
4.	Kim, JongMyeung: 1 article (03/2007)
5.	Lee, Dong Gun: 1 article (03/2007)
6.	Lee, Jin-Man: 1 article (03/2007)
7.	Lee, Sang-Han: 1 article (03/2007)
8.	Oh, Se Woong: 1 article (03/2007)

Related Diseases

1.	Infections 03/01/2007 - "aureus SMITH in the mouse systemic infection model; the efficacy of CW-270033 in this model was 2--7 fold higher than that of meropenem. "

Related Drugs and Biologics

1.	Meropenem (Merrem)